The good, the bad, and the ugly of the NDoH Annual Report 2015

When it comes to Annual Reports and audits, not every department in our country has as good a track record as the National Department of Health (NDoH). Sadly, however, the provincial departments don’t always fare as well.

The National department of Health presented its NDoH 2014-15 Annual Report and Annual Performance Plan (APP) recently. Ms Precious Matsoso, Director General, Department of Health, said the APP is designed to deliver on specific commitments such as improving the quality of health care, reducing health care costs, improving health management and leadership and implementing the re-engineering of primary health care. Continue reading

Advertisements

NCOP Social Services Medicines and Related Substances Amendment Bill

Bill [B6B-2014] Department of Health briefing held on 25 August 2015

What happens when an Act needs to be amended? At a recent briefing by the National Department of Health (NDoH) to the NCOP Social services Committee in Parliament on the Medicines and Related Substances Amendment Bill, I found out. Continue reading

National Health Insurance (NHI) Pilot Districts

A Portfolio meeting to receive an update from Minister of Health on National Health Insurance (NHI) Pilot Districts progress meeting was held on 21 August 2015. The Department of Health may have completed its part of the White Paper on NHI, but it is still tied up in Treasury. And until it is finally released, we are going to continue to see mistrust between the public and private sectors. Continue reading

Medical Innovation Bill – Central Drug Authority

Every time I visit the Houses of Parliament for the Portfolio of Health meetings, I am struck by how beautiful this venerable old building is.

I often think that if the walls could talk, they would reveal many secrets. This last week, however, I think the walls would have been shocked into silence to discover that the subject under discussion was marijuana. The purpose of the Medical Innovation Bill (MIB) is to make provision for the innovation of cannabinoids in medical treatment and to legalise its use for medical purposes, as well as for commercial and industrial use. Continue reading

The journey of a Bill

At the August 5 Portfolio Committee of Health meeting the Medicines and Related Substances Amendment Bill was considered and adopted.

A five-page document setting out the amendments that the Committee had earlier proposed and agreed to was tabled and the Committee approved all the amendments, and voted to accept the Bill as well. Continue reading